Drugs / Lispro Low Mix
Lispro Low Mix
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00279201 | Dec 2005 → Nov 2009 | type 2 diabetes mellitus | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lispro Low Mix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00279201 ↗ |
| Known as | insulin lispro mix 75/25 | “This study compared the durability of glycemic control of twice-daily insulin lispro mix 75/25 (LM75/25: 75% insulin lispro protamine suspension/25% lispro) and once-daily...” PMID 21270182 ↗ Feb 2011 |
| Known as | LM75/25 | “This study compared the durability of glycemic control of twice-daily insulin lispro mix 75/25 (LM75/25: 75% insulin lispro protamine suspension/25% lispro) and once-daily...” PMID 21270182 ↗ Feb 2011 |
| Modality | Protein / enzyme biologic | “insulin lispro mix 75/25” PMID 19885269 ↗ Sep 2008 |